Roy, I couldn't find your post where you expressed Enanta is no longer being priced by their HCV income, but instead now seems priced on it's pipeline.
That thesis seems like it's being validated today. (and reflexively, why share price fell so hard w/ EDP-721 being shelved.)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.